about
Codeine versus placebo for chronic cough in childrenExhaled nitric oxide levels to guide treatment for children with asthmaExhaled nitric oxide levels to guide treatment for adults with asthmaTailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adultsTailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adultsTailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adultsCodeine versus placebo for chronic cough in childrenSpirometry reference values in Indigenous Australians: a systematic review.Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis?Adenovirus species C is associated with chronic suppurative lung diseases in childrenBreathe Easier Online: evaluation of a randomized controlled pilot trial of an Internet-based intervention to improve well-being in children and adolescents with a chronic respiratory conditionDoes Ethnicity Influence Fractional Exhaled Nitric Oxide in Healthy Individuals?: A Systematic Review.Feasibility of a Peer-Led Asthma and Smoking Prevention Project in Australian Schools with High Indigenous Youth.A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils).The impact of viral respiratory infection on the severity and recovery from an asthma exacerbation.Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults.Protracted Bacterial Bronchitis in Children: Natural History and Risk Factors for Bronchiectasis.Exhaled nitric oxide levels to guide treatment for adults with asthma.Exhaled nitric oxide levels to guide treatment for children with asthma.Soluble receptor for advanced glycation end products (sRAGE) is present at high concentrations in the lungs of children and varies with age and the pattern of lung inflammation.Propensity of pneumococcal carriage serotypes to infect the lower airways of children with chronic endobronchial infections.Children with chronic cough: when is watchful waiting appropriate? development of likelihood ratios for assessing children with chronic cough.Randomised controlled trial of amoxycillin clavulanate in children with chronic wet cough.Cytokine responses to two common respiratory pathogens in children are dependent on interleukin-1β.A child chronic cough-specific quality of life measure: development and validation.Management based on exhaled nitric oxide levels adjusted for atopy reduces asthma exacerbations in children: A dual centre randomized controlled trial.A multicenter study on chronic cough in children : burden and etiologies based on a standardized management pathway.Airway cells from protracted bacterial bronchitis and bronchiectasis share similar gene expression profiles.Validation of a parent-proxy quality of life questionnaire for paediatric chronic cough (PC-QOL).Inhaled corticosteroids for bronchiectasisLetter in response to: Stark Pet alAmoxycillin-clavulanate for chronic wet cough in children: cautious interpretation of study findings warrantedDo Sex and Atopy Influence Cough Outcome Measurements in Children?An objective study of acid reflux and cough in children using an ambulatory pHmetry-cough loggerAsthma and protracted bronchitis: Who fares better during an acute respiratory infection?Quantified Tracheobronchomalacia Disorders and Their Clinical Profiles in ChildrenA bronchoscopic scoring system for airway secretions—airway cellularity and microbiological validation
P50
Q24186809-E2E7D4CE-3BC7-4102-92D5-20199A473569Q24186899-E05427A2-E341-4A79-B581-A7C6A15B1FE3Q24187001-A4B13959-B53B-46C6-919D-B234E0866ED5Q24240518-BE7F6629-ACCC-4DF8-A5D6-FCCD82B03BF3Q24242904-B8C7F2AB-11DB-4C4A-9A31-11AFB321FCD0Q24245542-5090546A-5C5D-4500-9C14-9C55852D5D78Q26471122-E28C0231-2B70-483C-BDC7-0E7392F6AC0FQ30249209-3D4A5032-764E-419F-ABE1-21F6209FB606Q34675706-935A4A43-7B48-43D8-A009-A813C16B8A88Q35008379-5572213F-0FED-4050-95CB-AD72B480AEF0Q36029798-A62E7E96-020A-41FC-B756-813C6C2BB646Q36284980-CD7DD7E3-C95E-45E5-A2F5-9D1D8C162574Q37675361-15291ED0-8C84-4A52-A8B0-8D5E90093EFFQ37799451-B98D00F9-8726-43EE-9039-6AA1A5B796F1Q37855366-A6CFB545-A638-4A93-8ED9-721588613DABQ38610303-28C72848-A015-4A28-99EC-56A25D521CCAQ38843153-DA01795F-19C6-4869-8210-19D4ED76472BQ38942532-8E318A81-8B14-40E0-80FE-352878542EFFQ39003057-FF7A1453-3251-4C12-AD29-1113D95C4024Q39636114-4AF9C19B-7B21-42A3-8726-2B0F0D2F208FQ40382092-0187A987-DB37-4660-AED9-44C18CF66358Q41697362-35F4F49B-F81D-4846-8ED7-691C19338C7DQ46466533-8C956868-EA2F-415B-9DB8-3E04208AA1FBQ47100848-25CBADE5-3EDB-444C-AE28-0A2DA3E5E177Q47835742-36C6C4C2-CFFE-4A1B-977C-9DD49AEFDDB7Q48074271-B53FD5D7-5E3C-4C44-BDF3-8F6EE8D0ECFFQ51392870-6D89A6CC-CEB7-4B54-83E3-688056E99438Q52724334-A0C88B4D-07AE-4AA0-A990-5EC54CD4D48AQ53064730-B1D72F5B-7902-4F85-983C-35E0D01C6E93Q57689274-9E3A02EA-0025-4E95-BB4E-DD9DAEB6E6BCQ58811357-8D2D95B2-E009-4530-96E9-980E5EC99A68Q58811374-553FB0D9-DFF0-4834-B78E-CBC6189B17A7Q58811379-EF869A56-65E1-4747-A726-61CBB6C61940Q58811398-212FA7D7-7105-450E-8B46-9E1794919B99Q58811407-86BCDD9C-1E63-4E08-8CB1-72E2B9DCE9E2Q58811422-C0372C21-71CD-4F2C-9EF0-AE074765ED82
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Helen L Petsky
@ast
Helen L Petsky
@en
Helen L Petsky
@es
Helen L Petsky
@nl
type
label
Helen L Petsky
@ast
Helen L Petsky
@en
Helen L Petsky
@es
Helen L Petsky
@nl
prefLabel
Helen L Petsky
@ast
Helen L Petsky
@en
Helen L Petsky
@es
Helen L Petsky
@nl
P106
P1153
12445981400
P31
P496
0000-0002-5315-9002